ロード中...
Evaluation of Oritavancin Use at a Community Hospital
Background: Oritavancin is a lipoglycopeptide antibiotic indicated for the treatment of acute bacterial skin and soft tissue infections. The prolonged half-life of this agent allows for a course of therapy to be completed with a single dose. Oritavancin was added to our formulary as an option for tr...
保存先:
| 出版年: | Hosp Pharm |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6050883/ https://ncbi.nlm.nih.gov/pubmed/30038448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0018578717746415 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|